Mixed serum-deprived and normal adipose-derived mesenchymal stem cells against acute lung ischemia-reperfusion injury in rats

American Journal of Translational Research

Volumn 7, Issue 2, 2015, Pages 209-231

  Sun, Cheuk Kwan ^a   Leu, Steve ^b   Hsu, Shu Yuan ^c   Zhen, Yen Yi ^b   Chang, Li Teh ^d   Tsai, Ching Yen ^e   Chen, Yung Lung ^b   Chen, Yen Ta ^b   Tsai, Tzu Hsien ^b   Lee, Fan Yen ^b   Sheu, Jiunn Jye ^b   Chang, Hsueh Wen ^f   Yip, Hon Kan ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d MEIHO UNIVERSITY   (Taiwan)

^e INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^f NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Cytotherapy; Inflammation; Lung ischemia reperfusion injury; Oxidative stress; Serum deprived mesenchymal stem cell

Indexed keywords

CASPASE 3; CD31 ANTIGEN; CD68 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GELATINASE B; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROSTAGLANDIN E2; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGEN TENSION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MALE; MESENCHYMAL STEM CELL; MICROSCOPY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; THORACOTOMY; WESTERN BLOTTING;

RATTUS; RODENTIA;

EID: 84925387417     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Rubenfeld GD and Herridge MS. Epidemiology and outcomes of acute lung injury. Chest 2007; 131: 554-562.
2. Fan E, Wilcox ME, Brower RG, Stewart TE, Mehta S, Lapinsky SE, Meade MO and Ferguson ND. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med 2008; 178: 1156-1163.
3. Esteban A, Anzueto A, Frutos F, Alia I, Brochard L, Stewart TE, Benito S, Epstein SK, Apezteguia C, Nightingale P, Arroliga AC, Tobin MJ; Mechanical Ventilation International Study G. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day in-ternational study. JAMA 2002; 287: 345-355.
4. Bittner HB, Binner C, Dahlberg P and Mohr FW. Reducing ischemia-reperfusion injury in clini-cal lung transplantation. Transplant Proc 2007; 39: 489-492.
5. Chamogeorgakis TP, Kostopanagiotou GG, Kalimeris CA, Kabouroglou GI, Kourtesis AN, Routsi CI, Dima CC and Toumpoulis IK. Effect of N-acetyl-L-cysteine on lung ischaemia reper-fusion injury in a porcine experimental model. ANZ J Surg 2008; 78: 72-77.
6. Chang H, Huang KL, Li MH, Hsu CW, Tsai SH and Chu SJ. Manipulations of core tempera-tures in ischemia-reperfusion lung injury in rabbits. Pulm Pharmacol Ther 2008; 21: 285-291.
7. Botha P, Jeyakanthan M, Rao JN, Fisher AJ, Prabhu M, Dark JH and Clark SC. Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 2007; 26: 1199-1205.
8. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D and collaboration CT. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363.
9. Wolf PS, Merry HE, Farivar AS, McCourtie AS and Mulligan MS. Stress-activated protein ki-nase inhibition to ameliorate lung ischemia reperfusion injury. J Thorac Cardiovasc Surg 2008; 135: 656-665.
10. McCourtie AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Mackinnon-Patterson B, Keech JC, Fitzsullivan E and Mulligan MS. Alveolar macrophage secretory products effect type 2 pneumocytes undergoing hypoxia-reoxygen-ation. Ann Thorac Surg 2008; 86: 1774-1779.
11. Hashimoto N, Takeyoshi I, Tsutsumi H, Sunose Y, Tokumine M, Totsuka O, Ohwada S, Matsumoto K and Morishita Y. Effects of a bra-dykinin B(2) receptor antagonist on ischemia-reperfusion injury in a canine lung transplan-tation model. J Heart Lung Transplant 2004; 23: 606-13.
12. Seekamp A, Mulligan MS, Till GO, Smith CW, Miyasaka M, Tamatani T, Todd RF 3rd and Ward PA. Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. Am J Pathol 1993; 143: 464-472.
13. Iwata T, Chiyo M, Yoshida S, Smith GN Jr, Mickler EA, Presson R Jr, Fisher AJ, Brand DD, Cummings OW and Wilkes DS. Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression. Transplantation 2008; 85: 417-426.
14. Garcia-Covarrubias L, Manning EW 3rd, Sorell LT, Pham SM and Majetschak M. Ubiquitin en-hances the Th2 cytokine response and attenu-ates ischemia-reperfusion injury in the lung. Crit Care Med 2008; 36: 979-982.
15. Geudens N, Wuyts WA, Rega FR, Vanau-denaerde BM, Neyrinck AP, Verleden GM, Lerut TE and Van Raemdonck DE. N-acetyl cysteine attenuates the inflammatory response in warm ischemic pig lungs. J Surg Res 2008; 146: 177-183.
16. Kostopanagiotou GG, Kalimeris KA, Arkado-poulos NP, Pafiti A, Panagopoulos D, Smyrniotis V, Vlahakos D, Routsi C, Lekka ME and Nakos G. Desferrioxamine attenuates minor lung in-jury following surgical acute liver failure. Eur Respir J 2009; 33: 1429-36.
17. Zheng S, Zhang WY, Zhu LW, Lin K and Sun B. Surfactant and inhaled nitric oxide in rats alle-viate acute lung injury induced by intestinal ischemia and reperfusion. J Pediatr Surg 2001; 36: 980-984.
18. Veldhuizen RA, Marcou J, Yao LJ, McCaig L, Ito Y and Lewis JF. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am J Physiol 1996; 270: L152-158.
19. Davani S, Marandin A, Mersin N, Royer B, Kantelip B, Herve P, Etievent JP and Kantelip JP. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascu-lar density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003; 108: II253-258.
20. Yuen CM, Sun CK, Lin YC, Chang LT, Kao YH, Yen CH, Chen YL, Tsai TH, Chua S, Shao PL, Leu S and Yip HK. Combination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after isch-emic stroke. J Transl Med 2011; 9: 141.
21. Schachinger V, Assmus B, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Yu J, Corti R, Mathey DG, Hamm CW, Tonn T, Dimmeler S and Zeiher AM. Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfu-sion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial. Eur J Heart Fail 2009; 11: 973-979.
22. Kolvenbach R, Kreissig C, Ludwig E and Cagiannos C. Stem cell use in critical limb isch-emia. J Cardiovasc Surg (Torino) 2007; 48: 39-44.
23. Assmus B, Rolf A, Erbs S, Elsasser A, Haber-bosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Tonn T, Dimmeler S, Dill T, Zeiher AM, Schachinger V and Investigators RA. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myo-cardial infarction. Circ Heart Fail 2010; 3: 89-96.
24. Tendera M, Wojakowski W, Ruzyllo W, Chojnowska L, Kepka C, Tracz W, Musialek P, Piwowarska W, Nessler J, Buszman P, Grajek S, Breborowicz P, Majka M and Ratajczak MZ. Intracoronary infusion of bone marrow-derived selected CD34 + CXCR4 + cells and non-se-lected mononuclear cells in patients with acute STEMI and reduced left ventricular ejec-tion fraction: results of randomized, multicen-tre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009; 30: 1313-1321.
25. Salgar S, Manning E, Ruiz P and Pham S. Mesenchymal Stem Cell (MSC) Therapy To Prevent Ischemia-Reperfusion Injury in Lung Transplantation. J Immunol 2010; 184: 145.124.
26. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T and Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100: II 247-256.
27. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS and Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-1201.
28. Le Blanc K, Tammik L, Sundberg B, Hayne-sworth SE and Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses indepen-dently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20.
29. Thum T, Bauersachs J, Poole-Wilson PA, Volk HD and Anker SD. The dying stem cell hypoth-esis: immune modulation as a novel mecha-nism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005; 46: 1799-1802.
30. Sheu JJ, Chua S, Sun CK, Chang LT, Yen CH, Wu CJ, Fu M and Yip HK. Intra-coronary adminis-tration of cyclosporine limits infarct size, at-tenuates remodeling and preserves left ven-tricular function in porcine acute anterior in-farction. Int J Cardiol 2011; 147: 79-87.
31. Zhu W, Chen J, Cong X, Hu S and Chen X. Hypoxia and serum deprivation-induced apop-tosis in mesenchymal stem cells. Stem Cells 2006; 24: 416-425.
32. Gupta N, Su X, Popov B, Lee JW, Serikov V and Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells im-proves survival and attenuates endotoxin-in-duced acute lung injury in mice. J Immunol 2007; 179: 1855-1863.
33. Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res 2008; 58: 88-111.